Skip to main content
Guhan Pharmaceutical Group Co., Ltd. logo

Guhan Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 000590 ISIN · CNE000000701 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,714 across all filing types
Latest filing 2024-08-28 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000590

About Guhan Pharmaceutical Group Co., Ltd.

https://www.tuspharma.cn

Guhan Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and sale of traditional Chinese medicine (TCM) and health-related products. The company is widely recognized for its flagship product, Guhan Yangsheng Jing, which is formulated based on ancient health preservation prescriptions discovered in the Mawangdui Han Dynasty Tombs. Its product portfolio includes oral liquids, tablets, and capsules designed to enhance vitality, support kidney function, and promote overall longevity. The organization integrates classical medical theories with modern pharmaceutical manufacturing processes to ensure product efficacy and safety. Beyond its core TCM offerings, the group engages in the production of chemical drugs and health supplements, targeting markets seeking natural wellness solutions. The company emphasizes the preservation of cultural heritage through the modernization of ancient medical wisdom.

Recent filings

Filing Released Lang Actions
关于聘任公司证券事务代表的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of a securities affairs representative by the company's board of directors. It includes details about the appointment, the representative's qualifications, and contact information. There is no financial data, report, or regulatory filing content beyond this appointment notice. The document is short (900 characters) and focuses on management/board-related information. Therefore, it fits best under Board/Management Information (MANG).
2024-08-28 Chinese
2024年半年度财务报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as a "2024 半年度财务报告" which translates to "2024 Half-Year Financial Report." It contains detailed financial statements including consolidated and parent company balance sheets, profit and loss statements, cash flow statements, and changes in equity for the half-year period ending June 30, 2024. The length of the document is substantial (15,000 characters), and it includes actual financial data and analysis rather than just an announcement or certification. This matches the definition of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year containing substantive financial data and analysis. Therefore, the document should be classified as an Interim / Quarterly Report (IR). H1 2024
2024-08-28 Chinese
关于公司股东国有股权无偿划转完成过户登记的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the completion of a share transfer (无偿划转) between state-owned shareholders, detailing the change in shareholding percentages and the completion of the registration of the share transfer. It does not contain financial statements, management discussion, or detailed financial data. It is a regulatory announcement about shareholding changes but not a major shareholding notification crossing thresholds (which usually involves crossing 5% or 10% thresholds in a different context). The document is short (895 characters) and focuses on share transfer completion and registration confirmation. This fits best under Regulatory Filings (RNS) as it is a general regulatory announcement about shareholding changes without fitting other more specific categories like MRQ or SHA. Therefore, the classification is RNS with high confidence.
2024-08-05 Chinese
关于控股股东之一致行动人部分股权被质押的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement regarding the pledge of shares by a controlling shareholder and its concerted actor. It details the number of shares pledged, the proportion of shares involved, and the purpose of the pledge. There is no financial statement, earnings data, or management discussion. The document is a regulatory disclosure about share pledging, which is a capital/financing related update. It is not an annual report, earnings release, or any other report type. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is short and focused on a specific financing event, supporting this classification with high confidence.
2024-07-26 Chinese
2024-032关于公司控股股东之一致行动人解除部分股权质押的公告
Share Issue/Capital Change Classification · 95% confidence The document is a short announcement regarding the release of a partial pledge on shares held by a controlling shareholder's concert party. It includes specific details about the number of shares released from pledge and references previous announcements. The content focuses on shareholding and pledge status changes, which is related to share capital and ownership structure but does not involve new share issuance or capital changes like stock splits. It is not a full financial report, earnings release, or management discussion. The document is an official announcement about share pledge status, fitting best under the category of Share Issue/Capital Change (SHA) as it relates to changes in share capital status (pledge release). The document length is short and it is not a report publication announcement or regulatory filing. Therefore, the classification is SHA with high confidence.
2024-07-18 Chinese
2024年半年度业绩预告
Earnings Release Classification · 95% confidence The document is a 2024 semi-annual performance forecast (业绩预告) for the period January 1 to June 30, 2024. It provides estimated net profit figures and explanations for the expected loss, but explicitly states that the financial data has not been audited and is preliminary. It is not a full interim or quarterly report containing actual financial statements or substantive financial data, but rather a forecast or earnings guidance. The document is short (748 characters) and serves as an announcement of expected financial results rather than a detailed report. Therefore, it fits best under Earnings Release (ER), which covers initial announcements of quarterly or periodical financial results with key highlights only. H1 2024
2024-07-10 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.